News|Webcasts|October 11, 2024
Insight-Driven Strategies: Elevating Patient Centricity in Clinical Trials
Author(s)IQVIA
Webinar Date/Time: Wednesday, November 13th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Advertisement
Join experts from IQVIA Biotech and IQVIA in a webinar focused on enhancing clinical trial conduct by prioritizing patient-centric approaches. Discover innovative strategies for recruiting and retaining diverse patient populations and learn how to operationalize insights to meet accessibility goals. Don’t miss this opportunity to gain valuable insights and improve trial outcomes!
In this webinar, experts from IQVIA Biotech and IQVIA will focus on enhancing site and country trial conduct by putting the patient at the heart of their studies. Explore solutions to the challenges faced in recruiting and retaining diverse patient populations and see how insights are operationalized to meet patient accessibility goals. We look forward to your participation!
Three key take-aways
Three key take-aways
- Importance of patient voice: Learn how integrating patient perspectives can improve trial outcomes and support an innovative patient-centric culture.
- Patient engagement strategies: Discover innovative approaches to recruit and engage participants and the strategic site support that fosters effective workflows among sponsors, sites and patients.
- Enhancing trial success through design and execution: Gain insights on clinical trial country prioritization and rethink your strategy, operations and delivery model to enhance diversity and trial success.
Speakers:
Erin Finot, M.S., MBA
Vice President, Immuno-Oncology and CAGT
Erin Finot, M.S., MBA, vice president of immuno-oncology and CAGT at IQVIA Biotech, leads strategic efforts to ensure high-quality services and innovative trial solutions for biotech sponsors. With over 20 years of experience in global clinical research and drug development, Finot’s therapeutic expertise guides sponsors through the dynamic landscape of immuno-oncology and cell and gene therapies.
Katie Shaw
Senior Director, Site & Patient Networks, Clinical Operations
In her role as senior director of site and patient networks for clinical operations at IQVIA, Katie Shaw is accountable for the data-driven strategy development and operational pull-through for the patient recruitment and enablement solutions. Shaw leverages 15 years of experience in the clinical research industry, specializing in patient recruitment and retention innovation in the areas of data science, technology and patient engagement, and operational integration of IQVIA strategies, products and services across the global multidisciplinary teams, sites and with customers who leverage IQVIA solutions.
Register Free:https://www.appliedclinicaltrialsonline.com/act_w/insight-driven
Vice President, Immuno-Oncology and CAGT
Erin Finot, M.S., MBA, vice president of immuno-oncology and CAGT at IQVIA Biotech, leads strategic efforts to ensure high-quality services and innovative trial solutions for biotech sponsors. With over 20 years of experience in global clinical research and drug development, Finot’s therapeutic expertise guides sponsors through the dynamic landscape of immuno-oncology and cell and gene therapies.
Katie Shaw
Senior Director, Site & Patient Networks, Clinical Operations
In her role as senior director of site and patient networks for clinical operations at IQVIA, Katie Shaw is accountable for the data-driven strategy development and operational pull-through for the patient recruitment and enablement solutions. Shaw leverages 15 years of experience in the clinical research industry, specializing in patient recruitment and retention innovation in the areas of data science, technology and patient engagement, and operational integration of IQVIA strategies, products and services across the global multidisciplinary teams, sites and with customers who leverage IQVIA solutions.
Register Free:
Articles in this issue
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- The Impact of ICH E6(R3) on Biospecimen Management
June 25th 2025
- The Top 5 Myths About eCOAs In 2025
March 25th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
3
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
4
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
5